Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for NHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 13.12M
March 31, 2026 13.30M
December 31, 2025 53.46M
September 30, 2025 94.87M
June 30, 2025 139.88M
March 31, 2025 170.81M
December 31, 2024 182.92M
September 30, 2024 200.08M
June 30, 2024 49.03M
March 31, 2024 56.00M
December 31, 2023 64.04M
September 30, 2023 72.33M
June 30, 2023 80.27M
March 31, 2023 88.62M
December 31, 2022 96.86M
September 30, 2022 104.93M
June 30, 2022 123.71M
March 31, 2022 131.58M
December 31, 2021 139.08M
September 30, 2021 146.93M
June 30, 2021 154.48M
March 31, 2021 160.89M
December 31, 2020 168.57M
September 30, 2020 175.88M
June 30, 2020 183.26M
Date Value
March 31, 2020 240.51M
December 31, 2019 207.80M
September 30, 2019 234.93M
June 30, 2019 266.86M
March 31, 2019 276.67M
December 31, 2018 78.05M
September 30, 2018 99.00M
June 30, 2018 109.93M
March 31, 2018 125.84M
December 31, 2017 126.75M
September 30, 2017 147.64M
June 30, 2017 148.51M
March 31, 2017 149.38M
December 31, 2016 150.23M
September 30, 2016 151.07M
June 30, 2016 151.89M
March 31, 2016 152.71M
December 31, 2015 153.51M
September 30, 2015 44.30M
June 30, 2015 45.08M
March 31, 2015 45.84M
December 31, 2014 46.60M
September 30, 2014 47.34M
June 30, 2014 48.07M
March 31, 2014 48.79M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
The Ensign Group, Inc. 2.129B
Regional Health Properties, Inc. 41.29M
Chemed Corp. 253.52M
Oncologix Tech, Inc. --
InnovAge Holding Corp. 89.20M